These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5684610)

  • 41. [Therapy of gout in surgical patients].
    Koch G; Schlosser GA
    Med Klin; 1968 Nov; 63(47):1897-9. PubMed ID: 5712110
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of gout with alternate-day hypo-uricaemic drugs.
    Nishizawa T; Nishida Y; Masuda T; Akaoka I
    Rheumatol Rehabil; 1978 Aug; 17(3):143-9. PubMed ID: 705170
    [No Abstract]   [Full Text] [Related]  

  • 43. Study of the effect of hypouricaemic therapy on serum lipid levels in gout patients.
    Darlington LG; Scott JT
    Adv Exp Med Biol; 1986; 195 Pt A():341-4. PubMed ID: 3728165
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparison of effects of various therapeutic methods of the urinary system in patients with gout. Observations on 195 patients with gout].
    Kawenoki-Minc E; Eyman E; Weryńska-Przybylska J; Brzozowska AM
    Reumatologia; 1977; 15(2):199-206. PubMed ID: 897378
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gout from the view of a special hospital for rheumatic patients].
    Klotz H; Prohaska E; Salmhofer H; Schmid L
    Wien Klin Wochenschr; 1971 Mar; 83(11):177-80. PubMed ID: 5314855
    [No Abstract]   [Full Text] [Related]  

  • 48. The influence of allopurinol on the course of gout. A study of 28 cases.
    Kawenoki-Minc E; Eyman E; Sopata I; Weryńska-Przybylska J
    Reumatologia; 1970; 8(3):177-92. PubMed ID: 5469423
    [No Abstract]   [Full Text] [Related]  

  • 49. Risks and benefits of drugs used in the management and prevention of gout.
    Conaghan PG; Day RO
    Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of the gouty diathesis with a xanthine oxidase inhibitor. A clinical trial of allopurinol].
    Nyfos L
    Ugeskr Laeger; 1967 Feb; 129(8):253-7. PubMed ID: 5599222
    [No Abstract]   [Full Text] [Related]  

  • 52. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 53. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Principles of current management of primary gout.
    Yü TF; Gutman AB
    Am J Med Sci; 1967 Dec; 254(6):893-907. PubMed ID: 4863805
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population.
    Pui K; Gow PJ; Dalbeth N
    J Rheumatol; 2013 Jun; 40(6):872-6. PubMed ID: 23457380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of hyperuricemia.
    Lowenthal DT
    Am Fam Physician; 1976 Jul; 14(1):98-100. PubMed ID: 937167
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical aspects of chronic gout].
    Otto W; Binder E
    Z Gesamte Inn Med; 1966 Sep; 21(18):562-7. PubMed ID: 5990726
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout].
    Kawenoki-Minc E
    Ter Arkh; 1987; 59(4):25-8. PubMed ID: 3589999
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels.
    García Puig J; Mateos Antón F; López Jiménez M; Conthe Gutiérrez P
    Metabolism; 1986 Dec; 35(12):1147-53. PubMed ID: 3784914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.